Pa Hong1, Seung Soo Kim2, Cheol Jeong3, Seung Hwan Hwang4, Tae Seob Kim5, Jung Heum Park6, Yun Gyu Song1, Yu Kwan Song7. 1. Department of Radiology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea. 2. Liting Plastic Surgery Clinic, Seoul, Korea. 3. Gangnam JC Plastic Surgery Clinic, Jinju, Gyeongnam, Korea. 4. Department of Plastic and Reconstruction Surgery, M-hub Clinic, Daegu, Korea. 5. The Door Plastic Surgery Clinic, Seoul, Korea. 6. Mighty Plastic Surgery Clinic, Seoul, Korea. 7. Soonsoo Hospital, 298, 7-27, Sangsin-ro, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, 18617, Korea. psongsuture@outlook.com.
Abstract
BACKGROUND: The Motiva Ergonomix™ Round SilkSurface (Establishment Labs Holdings Inc., Alajuela, Costa Rica) is the fifth generation of a silicone gel-filled breast implant that is commercially available in Korea. OBJECTIVES: In this study, we describe 4-year interim results of the safety of augmentation mammaplasty using the Motiva Ergonomix™ Round SilkSurface in Korean women. METHODS: In the current multicenter, retrospective study, we performed a retrospective review of medical records of a total of 1314 patients who received augmentation mammaplasty using the Motiva Ergonomix™ Round SilkSurface at our hospitals between September 1, 2016, and August 31, 2020. For safety assessment, we analyzed incidences of postoperative complications and Kaplan-Meier complication-free survival of the patients. RESULTS: We included a total of 873 patients (1746 breasts, mean age = 32.18 ± 6.88 years) in the current study. There were a total of 111 cases (12.70%) of postoperative complications; these include 24 cases (2.70%) of early seroma, 18 cases (2.10%) of hematoma, 18 cases (2.10%) of capsular contracture, 17 cases (1.95%) of dissatisfaction with shape, 16 cases (1.83%) of dissatisfaction with size, 9 cases (1.03%) of asymmetry, 6 cases (0.70%) of infection and 3 cases (0.34%) of rippling. Moreover, time-to-events were estimated at 918.34 ± 36.22 days (95% CI 845.44-988.52). CONCLUSIONS: Here, we describe 4-year interim results of the safety of augmentation mammaplasty using the Motiva Ergonomix™ Round SilkSurface in Korean women in a non-manufacturer-sponsored study. But further large-scale, prospective, multicenter studies with a long period of follow-up are warranted to establish our results. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to Table of Contents or the online Instructions to Authors www.springer.com/00266 .
BACKGROUND: The Motiva Ergonomix™ Round SilkSurface (Establishment Labs Holdings Inc., Alajuela, Costa Rica) is the fifth generation of a silicone gel-filled breast implant that is commercially available in Korea. OBJECTIVES: In this study, we describe 4-year interim results of the safety of augmentation mammaplasty using the Motiva Ergonomix™ Round SilkSurface in Korean women. METHODS: In the current multicenter, retrospective study, we performed a retrospective review of medical records of a total of 1314 patients who received augmentation mammaplasty using the Motiva Ergonomix™ Round SilkSurface at our hospitals between September 1, 2016, and August 31, 2020. For safety assessment, we analyzed incidences of postoperative complications and Kaplan-Meier complication-free survival of the patients. RESULTS: We included a total of 873 patients (1746 breasts, mean age = 32.18 ± 6.88 years) in the current study. There were a total of 111 cases (12.70%) of postoperative complications; these include 24 cases (2.70%) of early seroma, 18 cases (2.10%) of hematoma, 18 cases (2.10%) of capsular contracture, 17 cases (1.95%) of dissatisfaction with shape, 16 cases (1.83%) of dissatisfaction with size, 9 cases (1.03%) of asymmetry, 6 cases (0.70%) of infection and 3 cases (0.34%) of rippling. Moreover, time-to-events were estimated at 918.34 ± 36.22 days (95% CI 845.44-988.52). CONCLUSIONS: Here, we describe 4-year interim results of the safety of augmentation mammaplasty using the Motiva Ergonomix™ Round SilkSurface in Korean women in a non-manufacturer-sponsored study. But further large-scale, prospective, multicenter studies with a long period of follow-up are warranted to establish our results. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Entities:
Keywords:
Biofilms; Breast; Breast implants; Kaplan–Meier estimate; Magnetic resonance imaging; Seroma
Authors: N Poeppl; S Schreml; F Lichtenegger; A Lenich; M Eisenmann-Klein; L Prantl Journal: Aesthetic Plast Surg Date: 2007 Mar-Apr Impact factor: 2.326
Authors: Phoebe Jones; Maria Mempin; Honghua Hu; Durdana Chowdhury; Matthew Foley; Rodney Cooter; William P Adams; Karen Vickery; Anand K Deva Journal: Plast Reconstr Surg Date: 2018-10 Impact factor: 4.730
Authors: M Bradley Calobrace; Michael R Schwartz; Kamakshi R Zeidler; Troy A Pittman; Robert Cohen; W Grant Stevens Journal: Aesthet Surg J Date: 2017-12-13 Impact factor: 4.283
Authors: Sangdal Lee; Jeong Pil Jeong; Jung Youp Sung; Woo Sik Choi; Dong Seung Moon; Ho Chan Kim; Jae Hong Kim Journal: Aesthet Surg J Open Forum Date: 2021-11-09